Violet Therapeutics, Inc. — Form D
Violet Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-05. The offering totals $11.5M, of which $7.4M was reported sold. Industry: Other.
Offering
- Filed: 2023-05-05
- Form: D
- Accession: 0001974912-23-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $11.5M
- Amount sold: $7.4M
- Remaining: $4.0M
- Investors: 4
- Date of first sale: 2023-04-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-480940
Issuer
- Name: Violet Therapeutics, Inc.
- CIK: 0001974912
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: ONE MAIN STREET, CAMBRIDGE, MA, 02142
- Phone: 508-344-2319
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Jonathan Behr | Director | London, X0 |
| Meredith Fisher | Director | Half Moon Bay, CA |
| Atsushi Usami | Director | Boston, MA |
| William E Yelle | Director | Cambridge, MA |
| Meredith Fisher | Executive Officer | Half Moon Bay, CA |
| William E Yelle | Executive Officer | Cambridge, MA |
More